Face Up To Rosacea
Galderma Launches Online Support to Empower and Equip Rosacea Sufferers to Discuss the True Burden of Their Disease With a Dermatologist - Seite 2
revolutionize future rosacea appointments, leading to better
outcomes," says Kamel Chaouche MD PhD, Head of Global Medical
Affairs, Prescription, Galderma.
"Great consultations start when you as the patient come to the
visit with a list of signs, symptoms and triggers that bother you and
what treatments you've tried before that have or haven't worked. With
this information, we can really customize your treatment plan to you
and only you and ultimately help you break the cycle of rosacea,"
says Dr. Melinda Gooderham, Medical Director at the SKiN Centre for
Dermatology in Ontario, Canada.
Visit www.faceuptorosacea.com to create and download your
personalized appointment guide to take to your next appointment.
References:
1. National Rosacea Society 2018. New Study Finds 415 Million People
May Suffer from Rosacea Worldwide. Available at: https://www.rosac
ea.org/press/2018/july/new-study-finds-415-million-people-may-suff
er-from-rosacea-worldwide. Last accessed: October 2019.
2. Rosacea: Beyond the visible online report. Available at:
http://hosted.bmj.com/rosaceabeyondthevisible. Last accessed:
October 2019.
About Rosacea
Rosacea is a common inflammatory skin disease that presents
variable clinical characteristics, of which the most common are
flushing, persistent erythema, and inflammatory lesions. It mainly
affects the central areas of the face, such as the cheeks and nose.
The disease can affect both adult men and women, usually after the
age of 30. Additionally, symptoms such as stinging, burning and
increased sensitivity of the skin are common. The eyes are often
affected, and might present as red, dry or itchy.
Although the cause of the disease is still under debate, various
trigger factors are known, including spicy foods, alcohol, emotional
stress, sun/UV-exposure, hot baths and hot beverages. Demodex,
generally harmless mites, can also be found in the skin in an
elevated quantity in people with rosacea.
Rosacea may worsen over time if left untreated. People that
suspect they suffer from rosacea should visit their dermatologist or
healthcare provider for diagnosis and discuss what treatment is right
for them. Because rosacea is a highly visible disease, it is known to
cause embarrassment and anxiety in some patients, which in turn may
cause frustration and have a negative impact on their social life.
About Face up to rosacea
Face up to rosacea is a global awareness campaign, launched in
October 2019 by Galderma. The campaign aims to close the
communication gap between people with rosacea and dermatologists. By
encouraging meaningful conversations between the two parties, rosacea
sufferers will become increasingly aware of the advancement of
treatment options now available from their dermatologist to help them
break free from the negative cycle of rosacea.
About Galderma
Galderma, the world's largest independent global dermatology
company, was created in 1981 and is now present in over 100 countries
with an extensive product portfolio to treat a range of
dermatological conditions. The company partners with health care
practitioners around the world to meet the skin health needs of
people throughout their lifetime. Galderma is a leader in research
and development of scientifically defined and medically proven
innovative solutions for the skin. For more information, please visit
www.galderma.com.
Galderma media relations contact
Sébastien Cros
Global Communications
+41-21-642-76-94
media@galderma.com
ots Originaltext: Galderma
Im Internet recherchierbar: http://www.presseportal.de
personalized appointment guide to take to your next appointment.
References:
1. National Rosacea Society 2018. New Study Finds 415 Million People
May Suffer from Rosacea Worldwide. Available at: https://www.rosac
ea.org/press/2018/july/new-study-finds-415-million-people-may-suff
er-from-rosacea-worldwide. Last accessed: October 2019.
2. Rosacea: Beyond the visible online report. Available at:
http://hosted.bmj.com/rosaceabeyondthevisible. Last accessed:
October 2019.
About Rosacea
Rosacea is a common inflammatory skin disease that presents
variable clinical characteristics, of which the most common are
flushing, persistent erythema, and inflammatory lesions. It mainly
affects the central areas of the face, such as the cheeks and nose.
The disease can affect both adult men and women, usually after the
age of 30. Additionally, symptoms such as stinging, burning and
increased sensitivity of the skin are common. The eyes are often
affected, and might present as red, dry or itchy.
Although the cause of the disease is still under debate, various
trigger factors are known, including spicy foods, alcohol, emotional
stress, sun/UV-exposure, hot baths and hot beverages. Demodex,
generally harmless mites, can also be found in the skin in an
elevated quantity in people with rosacea.
Rosacea may worsen over time if left untreated. People that
suspect they suffer from rosacea should visit their dermatologist or
healthcare provider for diagnosis and discuss what treatment is right
for them. Because rosacea is a highly visible disease, it is known to
cause embarrassment and anxiety in some patients, which in turn may
cause frustration and have a negative impact on their social life.
About Face up to rosacea
Face up to rosacea is a global awareness campaign, launched in
October 2019 by Galderma. The campaign aims to close the
communication gap between people with rosacea and dermatologists. By
encouraging meaningful conversations between the two parties, rosacea
sufferers will become increasingly aware of the advancement of
treatment options now available from their dermatologist to help them
break free from the negative cycle of rosacea.
About Galderma
Galderma, the world's largest independent global dermatology
company, was created in 1981 and is now present in over 100 countries
with an extensive product portfolio to treat a range of
dermatological conditions. The company partners with health care
practitioners around the world to meet the skin health needs of
people throughout their lifetime. Galderma is a leader in research
and development of scientifically defined and medically proven
innovative solutions for the skin. For more information, please visit
www.galderma.com.
Galderma media relations contact
Sébastien Cros
Global Communications
+41-21-642-76-94
media@galderma.com
ots Originaltext: Galderma
Im Internet recherchierbar: http://www.presseportal.de
Diskutieren Sie über die enthaltenen Werte
Aktuelle Themen
Weitere Artikel des Autors
1 im Artikel enthaltener WertIm Artikel enthaltene Werte